These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27726383)

  • 1. Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.
    Enright HA; Malfatti MA; Zimmermann M; Ognibene T; Henderson P; Turteltaub KW
    Chem Res Toxicol; 2016 Dec; 29(12):1976-1986. PubMed ID: 27726383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC-Parallel accelerator and molecular mass spectrometry analysis of
    Baliu-Rodriguez D; Stewart BJ; Ognibene TJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123590. PubMed ID: 36669256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerator mass spectrometry-enabled studies: current status and future prospects.
    Arjomand A
    Bioanalysis; 2010 Mar; 2(3):519-41. PubMed ID: 20440378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly coupled high-performance liquid chromatography-accelerator mass spectrometry measurement of chemically modified protein and peptides.
    Thomas AT; Stewart BJ; Ognibene TJ; Turteltaub KW; Bench G
    Anal Chem; 2013 Apr; 85(7):3644-50. PubMed ID: 23413773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.
    White IN; Brown K
    Trends Pharmacol Sci; 2004 Aug; 25(8):442-7. PubMed ID: 15276714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
    Garner RC
    Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.
    Malfatti MA; Buchholz BA; Enright HA; Stewart BJ; Ognibene TJ; McCartt AD; Loots GG; Zimmermann M; Scharadin TM; Cimino GD; Jonas BA; Pan CX; Bench G; Henderson PT; Turteltaub KW
    Toxics; 2019 May; 7(2):. PubMed ID: 31075884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerator MS: its role as a frontline bioanalytical technique.
    Seymour MA
    Bioanalysis; 2011 Dec; 3(24):2817-23. PubMed ID: 22185281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New frontiers-accelerator mass spectrometry (AMS): Recommendation for best practices and harmonization from Global Bioanalysis Consortium Harmonization Team.
    Young GC; Seymour M; Dueker SR; Timmerman P; Arjomand A; Nozawa K
    AAPS J; 2014 Mar; 16(2):357-9. PubMed ID: 24500278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations.
    DeGregorio MW; Dingley KH; Wurz GT; Ubick E; Turteltaub KW
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):335-42. PubMed ID: 16047147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in biomedical applications of accelerator mass spectrometry.
    Hah SS; Henderson PT; Turteltaub KW
    J Biomed Sci; 2009 Jun; 16(1):54. PubMed ID: 19534792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.
    Kim SH; Kelly PB; Ortalan V; Browning ND; Clifford AJ
    Anal Chem; 2010 Mar; 82(6):2243-52. PubMed ID: 20163100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding value through accelerator mass spectrometry-enabled first in human studies.
    Seymour MA
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):640-647. PubMed ID: 27444819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Interface for the Direct Coupling of Small Liquid Samples to AMS.
    Ognibene TJ; Thomas AT; Daley PF; Bench G; Turteltaub KW
    Nucl Instrum Methods Phys Res B; 2015 Oct; 361():173-177. PubMed ID: 26456991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies.
    Gao L; Li J; Kasserra C; Song Q; Arjomand A; Hesk D; Chowdhury SK
    Anal Chem; 2011 Jul; 83(14):5607-16. PubMed ID: 21627104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasma.
    Prakash C; Shaffer CL; Tremaine LM; Liberman RG; Skipper PL; Flarakos J; Tannenbaum SR
    Drug Metab Lett; 2007 Aug; 1(3):226-31. PubMed ID: 19356047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research.
    Turteltaub KW; Vogel JS
    Curr Pharm Des; 2000 Jul; 6(10):991-1007. PubMed ID: 10828298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an intravenous microdose of 14C-labeled drug and accelerator mass spectrometry to measure absolute oral bioavailability in dogs; cross-comparison of assay methods by accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Miyaji Y; Ishizuka T; Kawai K; Hamabe Y; Miyaoka T; Oh-hara T; Ikeda T; Kurihara A
    Drug Metab Pharmacokinet; 2009; 24(2):130-8. PubMed ID: 19430168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
    Barker J; Garner RC
    Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.